These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4074048)

  • 1. D-penicillamine and neutrophilic agranulocytosis.
    Umeki S; Konishi Y; Yasuda T; Morimoto K; Terao A
    Arch Intern Med; 1985 Dec; 145(12):2271-2. PubMed ID: 4074048
    [No Abstract]   [Full Text] [Related]  

  • 2. Transient fetal myelosuppressive effect of D-penicillamine when used in pregnancy.
    Yalaz M; Aydogdu S; Ozgenc F; Akisu M; Kultursay N; Yagci RV
    Minerva Pediatr; 2003 Dec; 55(6):625-8. PubMed ID: 14676735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Wilson's disease. Introduction to current problems (early diagnosis and therapy)].
    Wewalka F
    Wien Z Inn Med; 1967; 48(12):461-5. PubMed ID: 5620586
    [No Abstract]   [Full Text] [Related]  

  • 4. [JRA infant of neutrophilic agranulocytosis during administration of D-penicillamine (author's transl)].
    Okada T; Ogawa K; Eguchi H; Yabana T; Hikita H; Kouno K; Matsuda J
    Ryumachi; 1979 Aug; 19(4):337-45. PubMed ID: 538541
    [No Abstract]   [Full Text] [Related]  

  • 5. Side-effects of long-term D-penicillamine therapy in rheumatoid arthritis.
    Perl S
    S Afr Med J; 1977 Oct; 52(18):710. PubMed ID: 146263
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immune deficiency during D-penicillamine treatment ].
    Michel FB; Bousquet J; Robinet-Levy M; Mary P
    Nouv Presse Med; 1977 Nov; 6(38):3546-7. PubMed ID: 600728
    [No Abstract]   [Full Text] [Related]  

  • 7. D-penicillamine.
    Singh S; Kohli V
    Indian Pediatr; 1991 Jul; 28(7):779-85. PubMed ID: 1800352
    [No Abstract]   [Full Text] [Related]  

  • 8. Toxic reactions to penicillamine in patients with Wilson's disease.
    Walshe JM
    Postgrad Med J; 1968 Oct; ():Suppl:6-8. PubMed ID: 5706614
    [No Abstract]   [Full Text] [Related]  

  • 9. Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease.
    Siafakas CG; Jonas MM; Alexander S; Herrin J; Furuta GT
    Am J Gastroenterol; 1998 Dec; 93(12):2544-6. PubMed ID: 9860423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical, therapeutic and isotopic study of familial Wilson's disease: desensitization to penicillamine D].
    Mirouze J; Jaffiol C; Mary P
    Mars Med; 1969; 106(6):495-503. PubMed ID: 4246638
    [No Abstract]   [Full Text] [Related]  

  • 11. [Nephrotic syndrome secondary to d-penicillamine in a patient with Wilson's disease].
    Castellví Suaña JM; Xiol Quingles X; Castellote Alonso J; Guardiola Capón J
    Rev Clin Esp; 1993 Oct; 193(6):343-4. PubMed ID: 8259463
    [No Abstract]   [Full Text] [Related]  

  • 12. [A case of agranulocytosis which occurred several hours after the readministration of D-penicillamine accompanied by shivering-chillness].
    Negishi M; Matsuda A; Kaga S; Kanemitsu H; Hashimoto M; Kobayashi K; Ide H
    Arerugi; 1995 Feb; 44(2):96-9. PubMed ID: 7726755
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lupoid syndrome due to D-penicillamine associated with Wilson's disease: clinical study of a case].
    Caille B; Harpey JP; Lejeune C; Sudre Y; Turpin R
    Ann Med Interne (Paris); 1971 Feb; 122(2):255-60. PubMed ID: 5579427
    [No Abstract]   [Full Text] [Related]  

  • 14. [2 cases of verruciform elastoma after prolonged administration of D-penicillamine].
    Sfar Z; Lakhoua M; Kamoun MR; Kamoun F; Hafsia M
    Ann Dermatol Venereol; 1982; 109(9):813-4. PubMed ID: 7158941
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acrodynia (comparative study of various chelating agents; curable agranulocytosis during treatment by penicillamine)].
    François R; Germain D; Pellet H; Moreau P; Pouillaude JM; Collard N
    Pediatrie; 1967; 22(3):341-6. PubMed ID: 5607348
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dermatological complications during treatment of Wilsons disease with D-penicillamine].
    Rimbaud P; Mirouze J; Mary P; Meynadier J
    Med Chir Dig; 1973; 2(1):3-8. PubMed ID: 4269689
    [No Abstract]   [Full Text] [Related]  

  • 17. [Agranulocytosis and myasthenia gravis probably induced by D-penicillamine in rheumatoid patients (author's transl)].
    Hoshi K; Mizushima Y
    Ryumachi; 1981 May; 21(3):234-42. PubMed ID: 7313901
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-term D-penicillamine therapy of Wilson's disease in childhood. Changes in blood coagulation and effects on the haematopoetic system].
    Hayek HW; Schnack H; Widhalm S
    Wien Klin Wochenschr; 1973 Feb; 85(8):122-5. PubMed ID: 4632215
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
    Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M
    J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity of penicillamine.
    Scheinberg IH
    Postgrad Med J; 1968 Oct; ():Suppl:11-4. PubMed ID: 5706603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.